The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of stereotactic radiosurgery or other local ablation followed by erlotinib for patients with EGFR mutation who have previously progressed on an EGFR tyrosine kinase inhibitor (TKI).
 
Jared Weiss
Consulting or Advisory Role - AstraZeneca; Biodesix; EMD Serono; Genentech; Lilly; OncoPlex Diagnostics
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Celgene (Inst); Merck (Inst); novartis (Inst); Pfizer (Inst)
 
Brian D. Kavanagh
Research Funding - Janssen (Inst)
 
Allison Mary Deal
No Relationships to Disclose
 
Timothy Zagar
Honoraria - Accuray; Vision RT
Consulting or Advisory Role - Accuray; Vision RT
Research Funding - Accuray; Vision RT
Travel, Accommodations, Expenses - Accuray; Vision RT
 
Lawrence Bruce Marks
Research Funding - elekta, morphormics, accuray (Inst)
Travel, Accommodations, Expenses - varian and elekta
 
Tom Stinchcombe
Consulting or Advisory Role - Abbvie; ARIAD; Boehringer Ingelheim
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech/Roche (Inst)
 
Hossein Borghaei
Honoraria - Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Lilly; Pfizer; Trovagene
Research Funding - Celgene (Inst); Merck (Inst); Millennium (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly
 
Howard Jack West
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Guardant Health; Merck; Novartis
Speakers' Bureau - ARIAD; Genentech/Roche
 
David E. Morris
Stock and Other Ownership Interests - St. Louis Cyberknife, LLC
 
Liza Cosca Villaruz
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck; Newlink Genetics (Inst); Pfizer (Inst)